InMode Ltd vs SS&C Technologies Holdings Inc. Common Stock — how do they compare? InMode Ltd trades at $14.29 (market cap $821.73M), while SS&C Technologies Holdings Inc. Common Stock trades at $83.64 (market cap $19.25B). The key difference: SS&C Technologies Holdings Inc. Common Stock is far larger — about 23.4× InMode Ltd's market cap, and SS&C Technologies Holdings Inc. Common Stock pays a 1.46% dividend while InMode Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold InMode Ltd for 28 Days and SS&C Technologies Holdings Inc. Common Stock for 0 Days on average.
| INMD | SSNC | |
|---|---|---|
Market Cap | $821.73M | $19.25B |
Volume | 337,645 | 1,341,767 |
Sector | Health | Technology |
52-Week High | $16.62 | $89.62 |
52-Week Low | $12.76 | $62.05 |
Typical Hold Time | 28 Days | 0 Days |
Enterprise Value | $325.07M | $26.59B |
Dividend Yield | — | 1.46% |
Signals from Pluang's Aura AI — not financial advice
InMode (INMD) trades at $14.305, up 0.03% today, with a bullish technical signal but mixed indicators. The company reported Q2 2026 revenue of $95.6M, consistent with the prior year, and maintains strong profitability with a net margin of 20.69%. Recent news includes the launch of Morpheus8 Cool and an unsolicited acquisition offer from Steel Partners at $16.75 per share.
The outlook is balanced: valuation appears attractive with a P/E of 11.8, but revenue stagnation and a recent earnings miss pose risks. Analyst sentiment is mixed with a slight hold bias. Upside potential exists from the acquisition offer and international growth, while cyclical softness and capital allocation concerns remain headwinds.
SSNC trades at $81.52, up 0.65% on the day, with a neutral technical signal. The company has consistently beaten earnings estimates in recent quarters (Q4 2025, Q1 2026, Q2 2026) and shows solid fundamentals, including a 13.16% net income margin and 12.73% ROE. Recent news highlights new client wins and AI-driven product enhancements, reinforcing its market position.
The outlook is positive, supported by strong analyst consensus (70.83% Buy rating) and a $91.50 price target, implying ~12% upside. Key risks include execution of growth initiatives and competitive pressures in the financial technology sector. The stock presents a compelling opportunity for investors seeking a fundamentally sound company with recurring revenue streams.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →SS&C Technologies Holdings, Inc. provides software and outsourced services for financial services and healthcare organizations, covering fund accounting, portfolio management, trading support, and regulatory reporting, and operates as a hedge fund and private equity administrator and mutual fund transfer agent.
Read more on SSNC →